Title

Appropriate Use Criteria for the Treatment of Basal Cell Carcinoma (BCC) Using Image-Guided Superficial Radiation Therapy

Authoring Organization

Publication Month/Year

July 22, 2024

Last Updated Month/Year

July 23, 2024

Document Type

Other

Country of Publication

US

Document Objectives

BCC is the most commonly diagnosed skin cancer in the United States. Of the 5.4 million cases of NMSC diagnosed each year, 8 out of 10 are BCC. While Mohs micrographic surgery has been the gold standard treatment for more than a decade3, innovation in noninvasive, radiation-based treatment technology has given patients access to a non-surgical option using Image-Guided Superficial Radiation Therapy (IGSRT). When delivered in accordance with DART evidence-based guidelines, IGSRT is shown to be safe and up to 99% effective at eradicating BCC. Locations without access to IGSRT can still employ various forms of radiation for the noninvasive treatment of patients who are not surgical candidates or who decline surgery.

Inclusion Criteria

Male, Female, Adult, Older adult

Health Care Settings

Ambulatory, Outpatient, Radiology services

Intended Users

Nurse, nurse practitioner, physician, physician assistant, radiology technologist

Scope

Treatment, Management

Diseases/Conditions (MeSH)

D002280 - Carcinoma, Basal Cell, D018295 - Neoplasms, Basal Cell

Keywords

basal cell carcinoma, BCC